| Serial Number | 79264508 |
| Word Mark | ABTIS |
| Filing Date | Wednesday, June 19, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, May 12, 2020 |
| Registration Number | 6050283 |
| Registration Date | Tuesday, May 12, 2020 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 25, 2020 |
| Goods and Services | Pharmaceutical agents affecting metabolism; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical products for the treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biotechnological preparations for medical purposes, namely, for the treatment of oncological, metabolic and ophthalmic diseases and disorders; drugs for medical purposes, namely, for treating cancer; drugs for medical purposes, namely, for treating diabetes; drugs for medical purposes, namely, for treating ocular disease; antibodies for medical purposes, namely, for the treatment of oncological, metabolic and ophthalmic diseases and disorders; pharmaceutical compositions for the treatment of oncological, metabolic and ophthalmic diseases and disorders; medicines for human purposes for the treatment of oncological, metabolic and ophthalmic diseases and disorders; nutraceuticals for therapeutic purposes for the treatment of cancer; nutraceuticals for therapeutic purposes for the treatment of diabetes; therapeutic drugs and agents, namely, antibody drug conjugate comprising antibody and chemical compound attached for the treatment of oncological, metabolic and ophthalmic diseases and disorders; anti-cancer preparations |
| Goods and Services | Research and development of vaccines and medicines; biotechnology research; biological research; crude medicines research; scientific research for medical purposes in the field of cancerous diseases; research on the subject of pharmaceuticals; medical research; clinical research in the field of oncology, metabolic disease and ophthalmology |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 15, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 15, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | AbTis Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Party Name | AbTis Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Party Name | AbTis Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Event Date | Event Description |
| Thursday, August 8, 2019 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Thursday, August 15, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, September 12, 2019 | NON-FINAL ACTION WRITTEN |
| Wednesday, September 25, 2019 | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW |
| Thursday, October 31, 2019 | REFUSAL PROCESSED BY MPU |
| Thursday, October 31, 2019 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, August 20, 2019 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, September 10, 2019 | ASSIGNED TO EXAMINER |
| Friday, September 13, 2019 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, October 11, 2019 | NON-FINAL ACTION WRITTEN |
| Saturday, October 12, 2019 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Saturday, November 16, 2019 | REFUSAL PROCESSED BY IB |
| Thursday, January 23, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 5, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, February 5, 2020 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, February 5, 2020 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Saturday, February 22, 2020 | NOTIFICATION PROCESSED BY IB |
| Tuesday, February 25, 2020 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 25, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 12, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, August 12, 2020 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Thursday, September 17, 2020 | FINAL DISPOSITION NOTICE SENT TO IB |
| Sunday, October 11, 2020 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Monday, May 12, 2025 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Friday, January 28, 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
| Wednesday, January 8, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, January 9, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, January 8, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, September 17, 2020 | FINAL DISPOSITION PROCESSED |